InvestorsHub Logo
icon url

weedisgreen

11/23/21 8:15 PM

#69252 RE: weedisgreen #69251

"The company does not disclose business figures. But one thing is clear: Aurora operates in a growing market. About 20 to 30,000 patients in Germany are currently receiving cannabis as medicine, primarily as a pain reliever drug. There could be ten times as many in the future if you compare Germany with countries in which cannabis has been approved for a long time. Aside from that:"
icon url

player1234

11/24/21 9:49 AM

#69254 RE: weedisgreen #69251

Sorry for the day the shorts get burned!



You have been a supporter of ACB and ACB management since the end of 2018 when the stock was trading above $150/share (split adjusted).

Since then, the shares are down 95%. I don't think the "shorts" are concerned.